JMP Securities Maintains Spruce Biosciences(SPRB.US) With Buy Rating, Maintains Target Price $3
JMP Securities analyst Jonathan Wolleben maintains $Spruce Biosciences(SPRB.US)$ with a buy rating, and maintains the target price at $3.According to TipRanks data, the analyst has a success rate of 4
Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Spruce Biosciences (SPRB) and Envista Holdings (NVST)
HC Wainwright & Co. Reiterates Neutral on Spruce Biosciences
H.C. Wainwright Maintains Spruce Biosciences(SPRB.US) With Hold Rating
H.C. Wainwright analyst Ram Selvaraju maintains $Spruce Biosciences(SPRB.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 42.2% and a total average return of 1.6%
Analysts' Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (KRON), Spruce Biosciences (SPRB) and ScPharmaceuticals (SCPH)
RBC Capital Reiterates Sector Perform on Spruce Biosciences, Maintains $2 Price Target
Spruce Biosciences Analyst Ratings
Spruce Biosciences GAAP EPS of -$0.22 Beats by $0.01, Revenue of $1.61M Beats by $0.69M
RBC Capital Maintains Spruce Biosciences(SPRB.US) With Hold Rating, Maintains Target Price $2
RBC Capital analyst Gregory Renza maintains $Spruce Biosciences(SPRB.US)$ with a hold rating, and maintains the target price at $2.According to TipRanks data, the analyst has a success rate of 44.8%
Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX), Spruce Biosciences (SPRB) and Gossamer Bio (GOSS)
Buy Rating Affirmed for Spruce Biosciences Amid Anticipated Positive Clinical Trial Outcomes and Strong Financial Position
Spruce Biosciences | 10-Q: Q2 2024 Earnings Report
Spruce Biosciences 2Q Rev $1.61M >SPRB
Express News | Spruce Biosciences Inc: Cash Runway Through End of 2025
Express News | Spruce Biosciences Q2 Operating Expenses USD 11.646 Million
Express News | Spruce Biosciences Q2 Income From Operations USD -10.036 Million
Express News | Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
Express News | Spruce Biosciences Q2 Basic EPS USD -0.22
Express News | Spruce Biosciences Q2 Net Income USD -9.181 Million